Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid for prevention of rebleeding in acute upper gastrointestinal bleeding
IRCT20190116042380N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in upper gastrointestinal bleeding (UGIB) (3 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Gastrointestinal bleeding. Started Jan 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on IRCT20190116042380N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190116042380N1.